377 related articles for article (PubMed ID: 24607787)
1. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
Lu W; Li Y
J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
[TBL] [Abstract][Full Text] [Related]
3. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
5. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
7. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6.
Zhang J; Yang Z; Li P; Bledsoe G; Chao L; Chao J
Mol Cell Biochem; 2013 Jul; 379(1-2):295-301. PubMed ID: 23666756
[TBL] [Abstract][Full Text] [Related]
8. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
9. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
10. Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma.
Zhu Y; Wang M; Zhao X; Zhang L; Wu Y; Wang B; Hu W
Oncotarget; 2017 Apr; 8(14):22825-22834. PubMed ID: 28423559
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
12. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin.
Torricelli C; Daveri E; Salvadori S; Valacchi G; Ietta F; Muscettola M; Carlucci F; Maioli E
Cancer Lett; 2015 Apr; 360(1):17-27. PubMed ID: 25661734
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
[TBL] [Abstract][Full Text] [Related]
15. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion.
Ma J; Lu W; Chen D; Xu B; Li Y
J Cell Biochem; 2017 Sep; 118(9):2968-2976. PubMed ID: 28247948
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
Zhang Y
Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
[TBL] [Abstract][Full Text] [Related]
18. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
20. Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer.
Arensman MD; Nguyen P; Kershaw KM; Lay AR; Ostertag-Hill CA; Sherman MH; Downes M; Liddle C; Evans RM; Dawson DW
Mol Cancer Res; 2015 Nov; 13(11):1509-19. PubMed ID: 26224368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
